TY - JOUR
T1 - How radical prostatectomy procedures have changed over the last 10 years in Italy
T2 - a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study
AU - The MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group
AU - Gacci, Mauro
AU - Artibani, Walter
AU - Bassi, Pierfrancesco
AU - Bertoni, Filippo
AU - Bracarda, Sergio
AU - Briganti, Alberto
AU - Carmignani, Giorgio
AU - Carmignani, Luca
AU - Conti, Giario
AU - Corvò, Renzo
AU - De Nunzio, Cosimo
AU - Fusco, Ferdinando
AU - Graziotti, Pierpaolo
AU - Greco, Isabella
AU - Maggi, Stefania
AU - Magrini, Stefano Maria
AU - Mirone, Vincenzo
AU - Montironi, Rodolfo
AU - Morgia, Giuseppe
AU - Muto, Giovanni
AU - Noale, Marianna
AU - Pecoraro, Stefano
AU - Porreca, Angelo
AU - Ricardi, Umberto
AU - Russi, Elvio
AU - Russo, Giorgio
AU - Salonia, Andrea
AU - Simonato, Alchiede
AU - Serni, Sergio
AU - Tomasini, Davide
AU - Tubaro, Andrea
AU - Zagonel, Vittorina
AU - Crepaldi, Gaetano
AU - Conti, Giario Natale
AU - Gacci, Mauro
AU - Alitto, Anna Rita
AU - Ambrosi, Enrica
AU - Antonelli, Alessandro
AU - Aristei, Cynthia
AU - Bardari, Franco
AU - Bardoscia, Lilia
AU - Barra, Salvina
AU - Bartoncini, Sara
AU - Basso, Umberto
AU - Becherini, Carlotta
AU - Bellavita, Rita
AU - Bergamaschi, Franco
AU - Berlingheri, Stefania
AU - Berruti, Alfredo
AU - Volpe, Alessandro
N1 - Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/5
Y1 - 2021/5
N2 - Purpose: Therapeutic strategies for prostate cancer (PCa) have been evolving dramatically worldwide. The current article reports on the evolution of surgical management strategies for PCa in Italy. Methods: The data from two independent Italian multicenter projects, the MIRROR-SIU/LUNA (started in 2007, holding data of 890 patients) and the Pros-IT-CNR project (started in 2014, with data of 692 patients), were compared. Differences in patients’ characteristics were evaluated. Multivariable logistic regression models were used to identify characteristics associated with robot-assisted (RA) procedure, nerve sparing (NS) approach, and lymph node dissection (LND). Results: The two cohorts did not differ in terms of age and prostate-specific antigen (PSA) levels at biopsy. Patients enrolled in the Pros-IT-CNR project more frequently were submitted to RA (58.8% vs 27.6%, p < 0.001) and NS prostatectomy (58.4% vs. 52.9%, p = 0.04), but received LND less frequently (47.7% vs. 76.7%, p < 0.001), as compared to the MIRROR-SIU/LUNA patients. At multivariate logistic models, Lower Gleason Scores (GS) and PSA levels were significantly associated with RA prostatectomy in both cohorts. As for the MIRROR-SIU/LUNA data, clinical T-stage was a predictor for NS (OR = 0.07 for T3, T4) and LND (OR = 2.41 for T2) procedures. As for Pros-IT CNR data, GS ≥ (4 + 3) and positive cancer cores ≥ 50% were decisive factors both for NS (OR 0.29 and 0.30) and LND (OR 7.53 and 2.31) strategies. Conclusions: PCa management has changed over the last decade in Italian centers: RA and NS procedures without LND have become the methods of choice to treat newly medium–high risk diagnosed PCa.
AB - Purpose: Therapeutic strategies for prostate cancer (PCa) have been evolving dramatically worldwide. The current article reports on the evolution of surgical management strategies for PCa in Italy. Methods: The data from two independent Italian multicenter projects, the MIRROR-SIU/LUNA (started in 2007, holding data of 890 patients) and the Pros-IT-CNR project (started in 2014, with data of 692 patients), were compared. Differences in patients’ characteristics were evaluated. Multivariable logistic regression models were used to identify characteristics associated with robot-assisted (RA) procedure, nerve sparing (NS) approach, and lymph node dissection (LND). Results: The two cohorts did not differ in terms of age and prostate-specific antigen (PSA) levels at biopsy. Patients enrolled in the Pros-IT-CNR project more frequently were submitted to RA (58.8% vs 27.6%, p < 0.001) and NS prostatectomy (58.4% vs. 52.9%, p = 0.04), but received LND less frequently (47.7% vs. 76.7%, p < 0.001), as compared to the MIRROR-SIU/LUNA patients. At multivariate logistic models, Lower Gleason Scores (GS) and PSA levels were significantly associated with RA prostatectomy in both cohorts. As for the MIRROR-SIU/LUNA data, clinical T-stage was a predictor for NS (OR = 0.07 for T3, T4) and LND (OR = 2.41 for T2) procedures. As for Pros-IT CNR data, GS ≥ (4 + 3) and positive cancer cores ≥ 50% were decisive factors both for NS (OR 0.29 and 0.30) and LND (OR 7.53 and 2.31) strategies. Conclusions: PCa management has changed over the last decade in Italian centers: RA and NS procedures without LND have become the methods of choice to treat newly medium–high risk diagnosed PCa.
KW - Lymph node dissection
KW - MIRROR SIU/LUNA study
KW - Nerve sparing
KW - Pros-IT CNR study
KW - Prostate cancer
KW - Robotic procedures
UR - http://www.scopus.com/inward/record.url?scp=85096172313&partnerID=8YFLogxK
U2 - 10.1007/s00345-020-03350-5
DO - 10.1007/s00345-020-03350-5
M3 - Article
SN - 0724-4983
VL - 39
SP - 1445
EP - 1452
JO - World Journal of Urology
JF - World Journal of Urology
IS - 5
ER -